alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II 

112TH CONGRESS 

2D SESSION S. 2641 

To extend the temporary suspension of duty on fluoropolymers containing 

95 percent or more by weight of the monomer units tetrafluoroethylene, 

hexafluoropropylene, and vinylidene fluoride. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Ms. KLOBUCHAR introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on 

fluoropolymers containing 95 percent or more by weight 

of the monomer units tetrafluoroethylene, 

hexafluoropropylene, and vinylidene fluoride. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2641 IS

1 SECTION 1. FLUOROPOLYMERS CONTAINING 95 PERCENT 

2 OR MORE BY WEIGHT OF THE MONOMER 

3 UNITS TETRAFLUOROETHYLENE, 

4 HEXAFLUOROPROPYLENE, AND VINYLIDENE 

5 FLUORIDE. 

6 (a) IN GENERAL.—Heading 9902.01.62 of the Har7 monized Tariff Schedule of the United States (relating to 

8 fluoropolymers containing 95 percent or more by weight 

9 of the monomer units tetrafluoroethylene, 

10 hexafluoropropylene, and vinylidene fluoride) is amended 

11 by striking the date in the effective period column and 

12 inserting ‘‘12/31/2015’’. 

13 (b) EFFECTIVE DATE.—The amendment made by 

14 subsection (a) applies with respect to goods entered, or 

15 withdrawn from warehouse for consumption, on or after 

16 the 15th day after the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AND STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 1998.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               MAR-31-1998
<CASH>                                       1,680,016
<SECURITIES>                                         0
<RECEIVABLES>                                3,993,185
<ALLOWANCES>                                    60,000
<INVENTORY>                                 11,375,907
<CURRENT-ASSETS>                            20,104,370
<PP&E>                                      68,323,862
<DEPRECIATION>                              15,180,408
<TOTAL-ASSETS>                              73,247,824
<CURRENT-LIABILITIES>                       26,291,073
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        846
<COMMON>                                       974,607
<OTHER-SE>                                  10,031,298
<TOTAL-LIABILITY-AND-EQUITY>                73,247,824
<SALES>                                      5,086,296
<TOTAL-REVENUES>                             5,109,355
<CGS>                                        9,241,454
<TOTAL-COSTS>                                2,108,186
<OTHER-EXPENSES>                               758,043
<LOSS-PROVISION>                                60,000
<INTEREST-EXPENSE>                           1,036,295
<INCOME-PRETAX>                            (6,998,328)
<INCOME-TAX>                               (2,585,000)
<INCOME-CONTINUING>                        (4,413,328)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (4,413,328)
<EPS-PRIMARY>                                    (.06)
<EPS-DILUTED>                                    (.06)
        

</TABLE>
**Exhibit 10.32**

 

**AMENDMENT NO.**** 1 TO**

 

**NEORXCORPORATION**

 

**KEYEXECUTIVE SEVERANCE AGREEMENT**

 

ThisAmendment, dated as of March 30, 2005, is entered into by and betweenNEORX CORPORATION (the “Company”) and SUSAN D. BERLAND (the “Executive”) withrespect to the Key Executive Severance Agreement between the Company and theExecutive dated as of October 25, 2004 (the “Agreement”) as follows:

 

1.               The first sentenceof Section 1 of the Agreement shall be amended by replacing “ninety (90)days” with “nine (9) months” in reference to advance notice of nonrenewal inthe future.

 

2.               The third sentenceof Section 5.5 of the Agreement (which relates to offset for otherearnings) shall be deleted in its entirety. The words “and Offset” shall be removed from the title of Section 5.5.  The words “and potential reduction” shall bedeleted from Section 5.1(c) of the Agreement.

 

3.               Except as amendedby this Amendment, the Agreement shall remain in full and force effect.

 

IN WITNESS WHEREOF, theparties have executed this Amendment as of the date first above written.

 
|   |                 | NeoRx Corporation                 |
|--------|----------------------|-----------------------------------|
|   |                 |                              |
|   | /s/ Susan D. Berland |                              | By: | /s/Anna L. Wight |   |
|   | Susan D. Berland     | Its:  Vice  President, Legal |
|        |                      |                                   |  |  |  |

 

----
Exhibit 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002

I, Dr. Earl  Abbott,  Chief  Executive  Officer of AAA Minerals  Inc.,  certify,
pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley  Act of 2002,  that  the  Annual  Report  on Form  10-KSB  of AAA
Minerals  Inc.,  for the fiscal year ended July 31, 2005 fully complies with the
requirements  of Section 13(a) or 15(d) of the  Securities  Exchange Act of 1934
and that the  information  contained in the Annual  Report on Form 10-KSB fairly
presents  in all  material  respects  the  financial  condition  and  results of
operations of AAA Minerals Inc.


/s/ Earl Abbott
- --------------------------
Dr. Earl Abbott
Chief Executive Officer
October 28, 2005
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-END>                               DEC-31-1997
<CASH>                                            1697
<SECURITIES>                                        87
<RECEIVABLES>                                     9733
<ALLOWANCES>                                    (1135)
<INVENTORY>                                         49
<CURRENT-ASSETS>                                 11943
<PP&E>                                           66319
<DEPRECIATION>                                 (50246)
<TOTAL-ASSETS>                                   28190
<CURRENT-LIABILITIES>                             5974
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           598
<OTHER-SE>                                       21618
<TOTAL-LIABILITY-AND-EQUITY>                     28190
<SALES>                                              0
<TOTAL-REVENUES>                                  9480
<CGS>                                                0
<TOTAL-COSTS>                                     7978
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   1679
<INCOME-TAX>                                      (30)
<INCOME-CONTINUING>                               1649
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      1649
<EPS-PRIMARY>                                      .35
<EPS-DILUTED>                                      .32
        

</TABLE>
Order entered April 2 7 , 2020

In The 

### Court of Appeals Fifth District of Texas at Dallas

No. 05

- 19

- 00439

- CV

JOHN PANIAGUA, ET AL ., Appellant s

V.

WEEKLEY HOMES, LLC, Appellee

On Appeal from the 298 th Judicial District Court

Dallas County, Texas Trial Court Cause No. DC

- 19

- 02097

ORDER

Befor e the Court is appellants’ unopposed motion for extension of time to

file their reply brief

. We GRANT the motion and ORDER the reply brief

received April 21, 20 20 filed as of the date of this order.

/s/ ERIN A. NOWELL JUSTICE
EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002

I, David S. Tierney, M.D., Chief Executive Officer of Valera Pharmaceuticals, Inc. certify that:

1. I have reviewed this Annual Report on Form 10-K of Valera Pharmaceuticals, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;

(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officer and I have
disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not
material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Date: February 22, 2007



|                          
|--------------------------
|/s/ David S. Tierney, M.D.
|David S. Tierney, M.D.    
|Chief Executive Officer
CERTIFICATION
      OF


CHIEF
      EXECUTIVE OFFICER


AND
      PRINCIPAL FINANCIAL OFFICER


**PURSUANT
      TO 18 U.S.C. SECTION 1350**






In
      connection with this Yearly Report of Alliance Recovery Corp. (the “Company”) on
      Form 10-KSB for the year ending December 31, 2006, as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, Peter
      Vaisler, Chief Executive Officer and Chief Financial Officer of the Company,
      certifies to the best of his knowledge, pursuant to 18 U.S.C. Sec. 1350, as
      adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:




1.
            Such
                Yearly Report on Form 10-KSB for the year ending December 31, 2006,
                fully complies with the requirements of section 13(a) or 15(d) of
                the
                Securities Exchange Act of 1934; and2.
            The
                information contained in such Yearly Report on Form 10-KSB for
                the year ending December 31, 2006, fairly presents, in all material
                respects, the financial condition and results of operations of Alliance
                Recovery Corp.




Dated:
      November 9, 2006




ALLIANCE
      RECOVERY CORP.




By: /s/
      Peter Vaisler


Peter
      Vaisler


Chief
      Executive Officer and


Principal
      Financial Officer
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                           3,881
<SECURITIES>                                         0
<RECEIVABLES>                                   51,317
<ALLOWANCES>                                     1,500
<INVENTORY>                                     45,722
<CURRENT-ASSETS>                                     0
<PP&E>                                         425,626
<DEPRECIATION>                                  82,115
<TOTAL-ASSETS>                                 507,499
<CURRENT-LIABILITIES>                                0
<BONDS>                                        230,472
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     116,274
<TOTAL-LIABILITY-AND-EQUITY>                   507,499
<SALES>                                        133,628
<TOTAL-REVENUES>                               178,515
<CGS>                                           89,632
<TOTAL-COSTS>                                  128,267
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               7,484
<INCOME-PRETAX>                                 32,903
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             32,903
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    32,903
<EPS-BASIC>                                       1.03
<EPS-DILUTED>                                     1.03


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employment and Training Administration

          - [TA-W-65,503]

Pursuant to Section 221 of the Trade Act of 1974, as amended, an investigation was initiated on March 6, 2009 in response to a petition filed by a company official on behalf of the workers of Gerber Technology, Richardson, Texas.

The petitioner has requested that the petition be withdrawn. Consequently, the investigation has been terminated.

Signed at Washington, DC, this 26th day of March 2009.

Richard Church,

Certifying Officer, Division of Trade Adjustment Assistance. 

[FR Doc. E9-8935 Filed 4-17-09; 8:45 am]

BILLING CODE 4510-FN-P
MARCUS GOGGINS,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D17-0990

_____________________________/

Opinion filed June 1, 2017.

An appeal from an order of the Circuit Court for Alachua County.

Mark W. Moseley, Judge.

Marcus Goggins, pro se, Appellant.

Pamela Jo Bondi, Attorney General, and Quentin Humphrey, Assistant Attorney 

General, Tallahassee, for Appellee.

PER CURIAM.

AFFIRMED.

WETHERELL, RAY, and MAKAR, JJ., CONCUR.
# Official Journal L 349/2007

| | ISSN 1725-2555 |
| --- | --- |
| Official Journal
  of the European Union | L 349 |
| | |
| English edition | Legislation | Volume 5031 December 2007 |

ISSN 1725-2555

Official Journal

of the European Union

L 349

English edition

Legislation

Volume 5031 December 2007

---

| Contents | | I   Acts adopted under the EC Treaty/Euratom Treaty whose publication is obligatory | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Council Regulation (EC) No 1526/2007 of 17 December 2007 amending Regulation (EC) No 2505/96 opening and providing for the administration of autonomous Community tariff quotas for certain agricultural and industrial products | 1 |
| | * | Council Regulation (EC) No 1527/2007 of 17 December 2007 amending Regulation (EC) No 1255/96 temporarily suspending the autonomous common customs tariff duties on certain industrial, agricultural and fishery products | 7 |

Contents

I   Acts adopted under the EC Treaty/Euratom Treaty whose publication is obligatory

page

REGULATIONS

*

Council Regulation (EC) No 1526/2007 of 17 December 2007 amending Regulation (EC) No 2505/96 opening and providing for the administration of autonomous Community tariff quotas for certain agricultural and industrial products

1

*

Council Regulation (EC) No 1527/2007 of 17 December 2007 amending Regulation (EC) No 1255/96 temporarily suspending the autonomous common customs tariff duties on certain industrial, agricultural and fishery products

7

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Jeremy Clayton GREENE, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-4671

District Court of Appeal of Florida, Second District.

Opinion filed May 2, 2018

Howard L. Dimmig, II, Public Defender, and Joanna Beth Conner, Assistant Public Defender, Bartow, for Appellant.

Pamela Jo Bondi, Attorney General, Tallahassee, and Linsey Sims-Bohnenstiehl, Assistant Attorney General, Tampa, for Appellee.

KELLY, Judge.

*283Jeremy Clayton Greene appeals from his convictions and sentences for attempting to commit a lewd or lascivious act in the presence of a child under the age of sixteen, driving without a valid license, and possession of an open container. We affirm his convictions and sentences without comment. However, we reverse and remand because the circuit court erred in imposing certain costs. Greene preserved this issue by filing a motion to correct sentencing error pursuant to Florida Rule of Criminal Procedure 3.800(b)(2). The motion was deemed denied when the circuit court did not rule on the motion within sixty days. *See* Fla. R. Crim. P. 3.800(b)(2)(B) ; *White v. State*, 32 So.3d 132, 132 (Fla. 2d DCA 2010).

"The statutory authority for all costs imposed, whether they are mandatory or discretionary, must be cited in the written order." *Sanders v. State*, 189 So.3d 946, 946 (Fla. 2d DCA 2016) (quoting *Kirby v. State*, 695 So.2d 889, 890 (Fla. 2d DCA 1997) ); *see also**Singletary v. State*, 198 So.3d 973, 974 (Fla. 2d DCA 2016). Here, the written cost order reflects various costs with no citation to statutory authority. These costs are therefore stricken. On remand, the circuit court may again impose these costs if it provides appropriate statutory authority for their assessment. *See**Sanders*, 189 So.3d at 946 ; *Vick v. State*, 37 So.3d 951, 952 (Fla. 2d DCA 2010).

Affirmed in part, reversed in part, and remanded with directions.

SLEET and ROTHSTEIN-YOUAKIM, JJ., Concur.
II 

112TH CONGRESS 

2D SESSION S. 2674 

To suspend temporarily the rate of duty on N-[(4-methoxymethyl)-1- 

phenylmethyl-4-piperidinyl]N-phenylpropanamide-ethanedioate. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the rate of duty on N-[(4- 

methoxymethyl)-1-phenylmethyl-4-piperidinyl]Nphenylpropanamide-ethanedioate. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. N-[(4-METHOXYMETHYL)-1-PHENYLMETHYL-4- 

4 PIPERIDINYL]N-PHENYLPROPANAMIDE5 ETHANEDIOATE. 

6 (a) IN GENERAL.—Subchapter II of chapter 99 of 

7 the Harmonized Tariff Schedule of the United States is 

8 amended by inserting in numerical sequence the following 

9 new heading: 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2674 IS

‘‘ 9902.01.00 N-[(4-methoxymethyl)-1- 

phenylmethyl-4- 

piperidinyl]Nphenylpropanamideethanedioate (CAS No. 

61086–13–3) (provided for 

in subheading 2924.29.95) Free No change No change On or before 

12/31/2015 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS